The “Compliant by Design Roadmap” is the first paper that was published by the ETERNAL project, and it served as the foundation for all subsequent tasks and developments within the initiative. This roadmap provides practical and strategic guidance for integrating sustainability into pharmaceutical development from the very beginning, ensuring that environmental and regulatory considerations are embedded throughout the product life cycle.
The project is EU-funded under Horizon Europe, and Asphalion acts as the regulatory partner, supporting the consortium in ensuring that all developments are fully aligned with regulatory frameworks while promoting sustainability and innovation.
By following the principles outlined in this paper, the ETERNAL consortium has been able to guide its efforts toward more efficient, safer, and environmentally responsible processes. It offers insights that are applicable to both academic research and industrial practice, helping teams navigate the complex challenges of sustainable pharmaceutical innovation.
Key aspects covered in the paper include:
The paper continues to be a vital resource for researchers, regulators, and industry professionals aiming to adopt “Compliant by Design” principles, ensuring that every new development considers both human health and environmental sustainability.
📌 Read the full paper here:
https://www.eternalproject.eu/news/compliant_by_design_roadmap/
By exploring this roadmap, professionals can gain valuable insights into how to integrate sustainable practices into their projects, support innovation, and contribute to a greener and safer pharmaceutical industry — with the guidance of Asphalion as the regulatory partner throughout this EU-funded initiative.
For more information about the ETERNAL project, visit www.eternalproject.eu
Need help in your Regulatory projects? Contact us! [email protected]
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
